Abstract Cyclosporine (CyA) is a well-known immunosuppressant with a narrow therapeutic window. Its bioavailability is affected by many other traditional drugs and herbal extracts. Cytochrome [...]
Contemporary management of pemphigus. Christoph M Hammers, Luisa Lunardon, Enno Schmidt, and Detlef Zillikens Introduction: The two major pemphigus variants, pemphigus vulgaris and [...]
Enrichment of total serum IgG4 in patients with pemphigus. T. Funakoshi, L. Lunardon, C.T. Ellebrecht, A.R. Nagler, C.E. O’Leary and A.S. Payne Summary Background: Pemphigus vulgaris (PV) and [...]
Luisa Lunardon, Kathleen J. Tsai, Kathleen J. Propert, Nicole Fett, John R. Stanley, Victoria P. Werth, Donald E. Tsai, Aimee S. Payne. Adjuvant rituximab therapy of pemphigus: a single center [...]
Rituximab for autoimmune blistering diseases: recent studies, new insights Luisa Lunardon and Aimee S. Payne Rituximab, an anti-CD20 monoclonal antibody, has been successfully used [...]